| 000 | 03034nam a22005415i 4500 | ||
|---|---|---|---|
| 001 | 978-3-642-23056-1 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083300.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 120507s2012 gw | s |||| 0|eng d | ||
| 020 |
_a9783642230561 _9978-3-642-23056-1 |
||
| 024 | 7 |
_a10.1007/978-3-642-23056-1 _2doi |
|
| 050 | 4 | _aRM1-950 | |
| 072 | 7 |
_aMMG _2bicssc |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615 _223 |
| 100 | 1 |
_aLever, Rebecca. _eeditor. |
|
| 245 | 1 | 0 |
_aHeparin - A Century of Progress _h[electronic resource] / _cedited by Rebecca Lever, Barbara Mulloy, Clive P. Page. |
| 264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2012. |
|
| 300 |
_aXIV, 459p. 79 illus., 4 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v207 |
|
| 505 | 0 | _aPart 1. Introduction -- Part 2. Unfractionated and Low Molecular Weight Heparins -- Part 3. Clinical Use of Heparin and LMWH -- Part 4. Non Anticoagulant Indictions for Heparin and Related Compounds -- Part 5. Heparin-like Entities. | |
| 520 | _aHeparins remain amongst the most commonly used drugs in clinical practice. Almost 100 years have passed since the initial discovery of this complex substance and, during this time, understanding of the nature and uses of heparin and related molecules has grown dramatically. The aim of this volume is to summarise the developments that have led to the current status of both heparins as drugs and the field of heparin research, with a focus on the particularly rapid progress that has been made over the past three decades. Individual sections are dedicated to the nature of heparin as a biological molecule, the current approaches and techniques that are used to ensure the safety and reliability of heparin as a medicine, the clinical pharmacology of heparin as an anticoagulant drug, effects and potential applications of heparin aside of those involving haemostasis and, finally, the nature and potential uses of heparin-like materials from both natural and synthetic sources. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aToxicology. | |
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 0 | _aInternal medicine. | |
| 650 | 0 | _aHematology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 650 | 2 | 4 | _aMolecular Medicine. |
| 650 | 2 | 4 | _aPharmaceutical Sciences/Technology. |
| 650 | 2 | 4 | _aInternal Medicine. |
| 650 | 2 | 4 | _aHematology. |
| 700 | 1 |
_aMulloy, Barbara. _eeditor. |
|
| 700 | 1 |
_aPage, Clive P. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783642230554 |
| 830 | 0 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v207 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-642-23056-1 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c102121 _d102121 |
||